latest news releases from the newsroom
Pride International, Inc.
Pride International, Inc. Provides Update On Status of Gulf of Mexico Fleet Following Hurricane Ike
HOUSTON, Sept. 16, 2008 (GLOBE NEWSWIRE) -- Pride International, Inc. (NYSE:PDE) reported today that the Pride Wyoming, a 250-foot mat slot jackup rig operating in the U.S. Gulf of Mexico, is missing and expected to be a total loss following Hurricane Ike. The rig's last location was at Ship Shoal 283, approximately 90 miles south of Houma, Louisiana. All rig personnel had been safely evacuated prior to the arrival of the storm.
Meritage Homes Corporation
Meritage Homes to Present At Deutsche Bank 2008 Homebuilding Symposium
SCOTTSDALE, Ariz., Sept. 16, 2008 (GLOBE NEWSWIRE) -- Meritage Homes Corporation (NYSE:MTH) a leading U.S. homebuilder, announced today that Meritage executive management will make a presentation to the investment community on Monday, September 22, 2008 at 11:00 a.m. ET at the Deutsche Bank 2008 Homebuilding Symposium in New York City. The Company's presentation will be webcast live and may be accessed, along with the presentation materials, through the "Investor Relations" page of the Meritage Homes website, http://www.meritagehomes.com. Participants should access the webcast event page at least five minutes before the live event. An archived version of the Company's presentation will also be available on this site following the presentation.
NASDAQ 100 Index Sets Record Milestone
NEW YORK, Sept. 16, 2008 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group (Nasdaq:NDAQ) today announced that futures contracts based on the NASDAQ-100 Index(r) have crossed the 5/25 milestone -- 500 million contracts traded/$25 trillion in notional value. Moreover, trading of futures on the NASDAQ-100 Index is fast approaching 600 million contracts worth over $25 trillion in notional value on the Chicago Mercantile Exchange.
Evotec Participates in the Sale of Direvo Biotech to Bayer Healthcare
HAMBURG, Germany, Sept. 16, 2008 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) announced today that the Company participates via convertible bonds in the sale of Direvo Biotech AG to Bayer HealthCare AG published this morning. Evotec holds convertible bonds valued at approximately EUR 5 million which Evotec received as part of the compensation for the sale of its equity holding in Direvo in May 2007.